APVO US

Aptevo Therapeutics Inc.(APVO US)

$1.61+0.000.00%Ext:$1.35-0.2616.36%(Market Closed · 23:47:19 UTC)

Financials

Income Statement

Balance Sheet Cash Flow

%ChgLast 12MReverse

Millions USD (ex. Per Share)			FY201312/31/2013	FY201412/31/2014	FY201512/31/2015	FY201612/31/2016	FY201712/31/2017	FY201812/31/2018	FY201912/31/2019	FY202012/31/2020	FY202112/31/2021	FY202212/31/2022	FY202312/31/2023	FY202412/31/2024	FY202512/31/2025	Last 12M03/31/2026
	Revenue												-	-	-	-
	-Cost of Revenue												-	0.4	0.2	0.1
	Gross Profit												-	-0.4	-0.2	-0.1
	-Operating Expenses												28.9	24.3	26.1	26.6
	+Selling, General & Admin												11.8	10.2	11.8	11.8
	+General And Administrative Expenses												11.8	10.2	11.8	11.8
	+Research and Development												17.1	14.4	14.5	14.8
	+Other Operating Expenses												-	-0.4	-0.2	-0.1
	Operating Income												-28.9	-24.6	-26.3	-26.7
	+Non Operating Income												10.2	0.5	0.3	0.4
	+Interest Income, Net												-	-	-	-
	+Interest Income												-	-	-	-
	-Interest Expense												-	-	-	-
	+Other Non-Op Income												10.2	0.5	0.3	0.4
	Pretax Income												-18.7	-24.1	-26.0	-26.3
	-Income Tax Expense												-	-	-	-
	Income from Cont Ops												-18.7	-24.1	-26.0	-26.3
	-Net Extraordinary Losses												-1.2	-	-	-
	+Discounted operations												1.2	-	-	-
	+XO & Accounting Changes												-	-	-	-
	Income Incl. MI												-17.4	-24.1	-26.0	-26.3
	-Minority Interests												-	-	-	-
	Net Income, GAAP												-17.4	-24.1	-26.0	-26.3
	-Prfrrd Div & Other												-	-	-	0.1
	Net Income Avail To Common												-17.4	-24.1	-27.5	-27.9
	Weighted Average Shs Out												20.0	767.0	3,155.0	1,329,787.0
	EPS												-834,044.0	-31,458.0	-87.3	-357.2
	Weighted Average Shs Out Dil												20.0	767.0	3,155.0	1,329,787.0
	EPS Diluted												-834,044.0	-31,458.0	-87.3	-357.2